Validation of the Montreal Cognitive Assessment (MoCA) Version 8.x and MoCA-MIS in Greece.

ConditionsMCI Dementia Mild Cognitive Impairment (MCI)

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age55-85

SponsorAristotle University Of Thessaloniki

About this trial

Objective: The purpose of this study is to assess the psychometric qualities of the Montreal Cognitive Assessment (MoCA) version 8.x in Greek, including the MoCA-MIS. We intend to examine the tool's reliability (internal consistency, test-retest reliability) and validity (construct validity, concurrent validity, and known-group validity).

Aim: The findings will support the tool's application for early cognitive impairment identification in clinical and research settings.

Eligibility criteria

Qualifiers

Participants between the ages of 55-85

Fluent in Greek to avoid misunderstandings during the assessment

Participants must be able to provide informed consent

Disqualifiers

History of severe psychiatric or neurological disorders apart from MCI/dementia

Patients having acute medical illnesses

Patients having severe hearing and/or visual impairments

Trial design

Treatments tested in this trial

Not listed

Trial groups

250 Participants

are grouped into 3 trial groups

Locations

Outpatient clinic of the 3rd Department of Psychiatry, School of Medicine, General University Hospital of Thessaloniki "AHEPA", Aristotle University of Thessaloniki, Greece.54636, Thessaloniki Greece

Sponsors and collaborators

Aristotle University Of Thessaloniki

Lead sponsor

MoCA Clinic and Institute

Collaborator

Source ClinicalTrials.gov